Zhonghong Eric Guan
![Zhonghong Eric Guan Zhonghong Eric Guan](https://cytokine-based-drugdevelopment.com/wp-content/uploads/sites/349/2024/02/fe32fb30-cb55-11ee-a5c2-525400cb626e-150x150.jpg)
Company: Mural Oncology
Job title: SVP, Head of Medical Affairs
Seminars:
Exploring Nemvaleukin Alfa Monotherapy & in Combination With Pembrolizumab in Patients With Advanced Solid Tumors 11:30 am
Outlining nemvaleukin as a novel engineered cytokine Revealing the design to selectively bind to intermediate-affinity interleukin-2 receptor (IL-2R) for preferential activation and expansion of tumor-killing CD8+ T cells and natural killer (NK) cells, with minimal expansion of regulatory T cells (Tregs) Discussing the potential to reduce native IL-2’s toxicities, thus allowing greater tolerability and efficacy…Read more
day: Conference Day Two